早期治疗HIV-1感染者DNA衰减动态:临床试验设计的实用考量
本研究通过微滴数字PCR纵向监测21例在HIV-1感染后6个月内启动cART者的总HIV-1 DNA水平,发现4年随访中位下降1.43 log10单位,统计模型显示cART治疗2年后病毒储存库达到设定点,提示设计干预试验需考虑2年等待期。
要点
- 早期治疗者总HIV-1 DNA在4年内中位下降1.43 log10单位。
- cART治疗2年后病毒储存库达到设定点。
- 基线HIV-1 DNA、病毒载量、CD4+计数及CD4+/CD8+比值与最终DNA水平相关。
核心结论
- 早期治疗个体在cART治疗2年后HIV-1储存库达到设定点,设计旨在影响潜伏储存库的干预试验应考虑2年等待期。
研究设计与样本
- 前瞻性纵向观察研究,纳入21例在估计HIV-1感染后6个月内启动cART的个体,用微滴数字PCR检测总HIV-1 DNA,在cART启动时、6个月及每年至第4年测量,采用混合效应模型进行统计建模。
主要发现
- 4年随访期间总HIV-1 DNA中位总体下降1.43 log10单位(IQR=1.17-1.69)。
- 基线总HIV-1 DNA(R2=0.68,P<0.001)、病毒载量(R2=0.54,P=0.012)、绝对CD4+ T细胞计数(R2=-0.47,P=0.031)及CD4+/CD8+比值(R2=-0.59,P=0.0046)与最终HIV-1 DNA测量值相关。
- 统计模型显示cART治疗2年后病毒储存库达到设定点。
临床怎么用
- 设计旨在降低潜伏HIV-1储存库或影响cART中断后病毒反弹动力学的干预试验时,应考虑2年cART等待期以利于结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Initiation of combination antiretroviral therapy (cART) soon after HIV-1 infection limits the establishment of viral reservoirs. Thus, early treated individuals are preferred candidates to evaluate novel viral remission strategies. However, their cART-dependent HIV-1 DNA decay dynamics are still poorly defined. This can hamper the design and interpretation of results from clinical trials intended to further reduce viral reservoirs. OBJECTIVES: To clarify the duration of cART needed for the HIV-1 reservoir to be stabilized in early treated individuals. METHODS: We characterized the longitudinal decline of total HIV-1 DNA levels by droplet digital PCR in 21 individuals initiating cART within 6 months after estimated HIV-1 acquisition. Measurements were taken at cART initiation, after 6 months and annually until Year 4. Correlations between virological and clinical parameters were statistically analysed. Statistical modelling was performed applying a mixed-effects model. RESULTS: Total HIV-1 DNA experienced a median overall decrease of 1.43 log10 units (IQR = 1.17-1.69) throughout the 4 years of follow-up. Baseline levels for total HIV-1 DNA, viral load, absolute CD4+ T cell count and CD4+/CD8+ ratio correlate with final HIV-1 DNA measurements (R2 = 0.68, P < 0.001; R2 = 0.54, P = 0.012; R2 = -0.47, P = 0.031; and R2 = -0.59, P = 0.0046, respectively). Statistical modelling shows that after 2 years on cART the viral reservoir had reached a set point. CONCLUSIONS: A waiting period of 2 years on cART should be considered when designing interventions aiming to impact latent HIV-1 reservoir levels and viral rebound kinetics after cART discontinuation, in order to facilitate interpretation of results and enhance the chance of viral control.
引用
- Bayón-Gil Á, Puertas MC, Urrea V, et al. HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design. J Antimicrob Chemother. 2020. PMID: 32335675. doi:10.1093/jac/dkaa139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。